| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| durvalumab | programmed cell death 1 ligand 1 | biotech | Successful target | TTD , drugbank , DGIDB | Neoplasms[MeSHID:D009369] Cells[MeSHID:D002477] Disease[MeSHID:D004194] Carcinoma Transitional Cell[MeSHID:D002295] Small cell carcinoma of lung[MeSHID:D055752] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver carcinoma[MeSHID:D006528] Biliary Tract Cancer[MeSHID:D001661] melanoma[MeSHID:D008545] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Malignant Neoplasms[MeSHID:D009369] Pancreatic Ductal[MeSHID:D021441] |
7.96 | approved,investigational | inhibitor,antibody |
| click here to return to the previous page | ||||||||